Photo from Cancer at Cedars-Sinai/X
Apr 28, 2024, 12:40
Cancer at Cedars-Sinai is now recruiting patients with advanced NSCLC in a clinical trial
Cancer at Cedars-Sinai posted on X/Twitter:
“If you have advanced non-small cell lung cancer, you may be eligible for a clinical trial that compares usual treatment options to a study treatment combining Keytruda (pembrolizumab) and Cyramza (ramucirumab).”
Source: Cancer at Cedars-Sinai/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14